Literature DB >> 31324880

Two weeks of moderate hypoxia improves glucose tolerance in individuals with type 2 diabetes.

Kara L Marlatt1, Frank L Greenway1, J Kyle Schwab2, Eric Ravussin3.   

Abstract

We previously showed that nightly exposure to moderate hypoxia reduces fasting glucose levels and improves both whole-body skeletal muscle and hepatic insulin sensitivity in individuals with obesity. The goal of this study was to extend this observation in an "at home" setting and determine if nightly exposure to moderate hypoxia improves glucose tolerance in individuals with type 2 diabetes. Eight adults, ages 20-65 years with type 2 diabetes enrolled in our study and slept for 14 consecutive nights at home in a hypoxic tent maintained at 15% O2 (~2400 m). The primary endpoint was insulin sensitivity (Matsuda Index) calculated from a 75-g oral glucose tolerance test. Secondary endpoints included calculations of insulin secretion and beta-cell function, including the area-under-the-curve (AUC) for glucose and insulin, the Insulinogenic Index, and the Disposition Index. We observed the Matsuda Index trended towards a 29% increase following 14 nights of moderate hypoxia (from 1.7 ± 0.7 to 2.2 ± 1.7; p = 0.06). Two-hour glucose AUC was significantly reduced from 501 ± 99 to 439 ± 65 mg/dL × h (p = 0.01). We conclude that 14 nights of moderate hypoxia improves glucose tolerance in individuals with type 2 diabetes. Future studies should confirm whether exposure to moderate hypoxia consistently improves glucose homeostasis in larger sample sizes.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31324880      PMCID: PMC6980201          DOI: 10.1038/s41366-019-0422-0

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  3 in total

Review 1.  The impact of hypoxia exposure on glucose homeostasis in metabolically compromised humans: A systematic review.

Authors:  Veerle van Hulten; Rens L J van Meijel; Gijs H Goossens
Journal:  Rev Endocr Metab Disord       Date:  2021-04-14       Impact factor: 6.514

2.  The transcriptional coregulator CITED2 suppresses expression of IRS-2 and impairs insulin signaling in endothelial cells.

Authors:  Britta Kunkemoeller; Kuangyang Chen; Sam M Lockhart; Xuanchun Wang; Christian Rask-Madsen
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-06-21       Impact factor: 5.900

3.  Systematic evaluation of the association between hemoglobin levels and metabolic profile implicates beneficial effects of hypoxia.

Authors:  Juha Auvinen; Joona Tapio; Ville Karhunen; Johannes Kettunen; Raisa Serpi; Elitsa Y Dimova; Dipender Gill; Pasi Soininen; Tuija Tammelin; Juha Mykkänen; Katri Puukka; Mika Kähönen; Emma Raitoharju; Terho Lehtimäki; Mika Ala-Korpela; Olli T Raitakari; Sirkka Keinänen-Kiukaanniemi; Marjo-Riitta Järvelin; Peppi Koivunen
Journal:  Sci Adv       Date:  2021-07-14       Impact factor: 14.136

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.